EDGAR Filing Documents for 0001193125-22-139623

Form 8-K - Current report:

SEC Accession No. 0001193125-22-139623

Filing Date

2022-05-04

Accepted

2022-05-04 09:03:07

Documents

Period of Report

2022-05-03

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d333816d8k.htm iXBRL	8-K	64786
2	EX-3.1	d333816dex31.htm	EX-3.1	106372
3	EX-3.2	d333816dex32.htm	EX-3.2	104710
4	EX-3.3	d333816dex33.htm	EX-3.3	7468
5	EX-4.1	d333816dex41.htm	EX-4.1	86559
6	EX-4.2	d333816dex42.htm	EX-4.2	86090
7	EX-5.1	d333816dex51.htm	EX-5.1	7087
8	EX-10.1	d333816dex101.htm	EX-10.1	196887
9	EX-99.1	d333816dex991.htm	EX-99.1	11896
	Complete submission text file	0001193125-22-139623.txt		976830

Data Files

Seq	Description	Document	Type	Size
10	XBRL TAXONOMY EXTENSION SCHEMA	alna-20220503.xsd	EX-101.SCH	2871
11	XBRL TAXONOMY EXTENSION LABEL LINKBASE	alna-20220503_lab.xml	EX-101.LAB	19482
12	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	alna-20220503_pre.xml	EX-101.PRE	12163
14	EXTRACTED XBRL INSTANCE DOCUMENT	d333816d8k_htm.xml	XML	3796

Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462

Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577

Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)